Loading…

Kidney transplantation in sensitized recipients; a single center experience

A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Korean medical science 2009, 24(0), , pp.143-147
Main Authors: Kim, Sun Moon, Lee, Chungsik, Lee, Jung Pyo, Kim, Eun Man, Ha, Jongwon, Kim, Sang Joon, Park, Myoung Hee, Ahn, Curie, Kim, Yon Su
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173
cites cdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173
container_end_page S147
container_issue Suppl 1
container_start_page S143
container_title Journal of Korean medical science
container_volume 24 Suppl
creator Kim, Sun Moon
Lee, Chungsik
Lee, Jung Pyo
Kim, Eun Man
Ha, Jongwon
Kim, Sang Joon
Park, Myoung Hee
Ahn, Curie
Kim, Yon Su
description A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.
doi_str_mv 10.3346/jkms.2009.24.S1.S143
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_574478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66890969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</originalsourceid><addsrcrecordid>eNpVkV9LHDEUxYO0VGv7DaTMU_Fltvlzk0kQCiKtikKh2ueQzdyxcWczYzJbaj-9GXexLQRuwj3n3Et-hBwxuhAC1Kf71TovOKVmwWFxw8oBsUcOmDS6VkI2r8qdMlZrI2CfvM35nlIuJRdvyD4zzIAEOCBXV6GN-FhNycU89i5ObgpDrEKsMsYcpvAH2yqhD2PAOOWTylU5xLseK1_emCr8PWIqPY_vyOvO9Rnf7-oh-fH1y-3ZRX397fzy7PS69iDMVDtntJaNhGXDQSBA67STbUu5k6ipN52nQisluGup0pQB0E45xKU0rWaNOCTH29yYOrvywQ4uPNe7wa6SPf1-e2llA9DoIv28lY6b5RrbeeXkejumsHbp8dn4fyeGnyXml-VKCE5lCfi4C0jDwwbzZNche-zLT-GwyVYpbahRpghhK_RpyDlh9zKEUTsDszMwOwOzHOwNszOwYvvw74J_TTtC4gmVxpSL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66890969</pqid></control><display><type>article</type><title>Kidney transplantation in sensitized recipients; a single center experience</title><source>PubMed Central (Open Access)</source><creator>Kim, Sun Moon ; Lee, Chungsik ; Lee, Jung Pyo ; Kim, Eun Man ; Ha, Jongwon ; Kim, Sang Joon ; Park, Myoung Hee ; Ahn, Curie ; Kim, Yon Su</creator><creatorcontrib>Kim, Sun Moon ; Lee, Chungsik ; Lee, Jung Pyo ; Kim, Eun Man ; Ha, Jongwon ; Kim, Sang Joon ; Park, Myoung Hee ; Ahn, Curie ; Kim, Yon Su</creatorcontrib><description>A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.</description><identifier>ISSN: 1011-8934</identifier><identifier>EISSN: 1598-6357</identifier><identifier>DOI: 10.3346/jkms.2009.24.S1.S143</identifier><identifier>PMID: 19194544</identifier><language>eng</language><publisher>Korea (South): The Korean Academy of Medical Sciences</publisher><subject>Adult ; Antibodies, Monoclonal - pharmacology ; Antibodies, Monoclonal, Murine-Derived ; Antigens, CD20 - biosynthesis ; Biopsy ; Female ; Graft Rejection ; Graft Survival ; Histocompatibility Testing - methods ; Humans ; Immunoglobulins - chemistry ; Kidney Transplantation - methods ; Male ; Middle Aged ; Original ; Plasmapheresis ; Rituximab ; Transplantation Conditioning ; 의학일반</subject><ispartof>Journal of Korean Medical Science, 2009, 24(0), , pp.143-147</ispartof><rights>Copyright © 2009 The Korean Academy of Medical Sciences 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</citedby><cites>FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633205/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633205/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,4011,27905,27906,27907,53773,53775</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19194544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001315820$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Sun Moon</creatorcontrib><creatorcontrib>Lee, Chungsik</creatorcontrib><creatorcontrib>Lee, Jung Pyo</creatorcontrib><creatorcontrib>Kim, Eun Man</creatorcontrib><creatorcontrib>Ha, Jongwon</creatorcontrib><creatorcontrib>Kim, Sang Joon</creatorcontrib><creatorcontrib>Park, Myoung Hee</creatorcontrib><creatorcontrib>Ahn, Curie</creatorcontrib><creatorcontrib>Kim, Yon Su</creatorcontrib><title>Kidney transplantation in sensitized recipients; a single center experience</title><title>Journal of Korean medical science</title><addtitle>J Korean Med Sci</addtitle><description>A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.</description><subject>Adult</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antigens, CD20 - biosynthesis</subject><subject>Biopsy</subject><subject>Female</subject><subject>Graft Rejection</subject><subject>Graft Survival</subject><subject>Histocompatibility Testing - methods</subject><subject>Humans</subject><subject>Immunoglobulins - chemistry</subject><subject>Kidney Transplantation - methods</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Plasmapheresis</subject><subject>Rituximab</subject><subject>Transplantation Conditioning</subject><subject>의학일반</subject><issn>1011-8934</issn><issn>1598-6357</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkV9LHDEUxYO0VGv7DaTMU_Fltvlzk0kQCiKtikKh2ueQzdyxcWczYzJbaj-9GXexLQRuwj3n3Et-hBwxuhAC1Kf71TovOKVmwWFxw8oBsUcOmDS6VkI2r8qdMlZrI2CfvM35nlIuJRdvyD4zzIAEOCBXV6GN-FhNycU89i5ObgpDrEKsMsYcpvAH2yqhD2PAOOWTylU5xLseK1_emCr8PWIqPY_vyOvO9Rnf7-oh-fH1y-3ZRX397fzy7PS69iDMVDtntJaNhGXDQSBA67STbUu5k6ipN52nQisluGup0pQB0E45xKU0rWaNOCTH29yYOrvywQ4uPNe7wa6SPf1-e2llA9DoIv28lY6b5RrbeeXkejumsHbp8dn4fyeGnyXml-VKCE5lCfi4C0jDwwbzZNche-zLT-GwyVYpbahRpghhK_RpyDlh9zKEUTsDszMwOwOzHOwNszOwYvvw74J_TTtC4gmVxpSL</recordid><startdate>200901</startdate><enddate>200901</enddate><creator>Kim, Sun Moon</creator><creator>Lee, Chungsik</creator><creator>Lee, Jung Pyo</creator><creator>Kim, Eun Man</creator><creator>Ha, Jongwon</creator><creator>Kim, Sang Joon</creator><creator>Park, Myoung Hee</creator><creator>Ahn, Curie</creator><creator>Kim, Yon Su</creator><general>The Korean Academy of Medical Sciences</general><general>대한의학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>200901</creationdate><title>Kidney transplantation in sensitized recipients; a single center experience</title><author>Kim, Sun Moon ; Lee, Chungsik ; Lee, Jung Pyo ; Kim, Eun Man ; Ha, Jongwon ; Kim, Sang Joon ; Park, Myoung Hee ; Ahn, Curie ; Kim, Yon Su</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antigens, CD20 - biosynthesis</topic><topic>Biopsy</topic><topic>Female</topic><topic>Graft Rejection</topic><topic>Graft Survival</topic><topic>Histocompatibility Testing - methods</topic><topic>Humans</topic><topic>Immunoglobulins - chemistry</topic><topic>Kidney Transplantation - methods</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Plasmapheresis</topic><topic>Rituximab</topic><topic>Transplantation Conditioning</topic><topic>의학일반</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Sun Moon</creatorcontrib><creatorcontrib>Lee, Chungsik</creatorcontrib><creatorcontrib>Lee, Jung Pyo</creatorcontrib><creatorcontrib>Kim, Eun Man</creatorcontrib><creatorcontrib>Ha, Jongwon</creatorcontrib><creatorcontrib>Kim, Sang Joon</creatorcontrib><creatorcontrib>Park, Myoung Hee</creatorcontrib><creatorcontrib>Ahn, Curie</creatorcontrib><creatorcontrib>Kim, Yon Su</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Journal of Korean medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Sun Moon</au><au>Lee, Chungsik</au><au>Lee, Jung Pyo</au><au>Kim, Eun Man</au><au>Ha, Jongwon</au><au>Kim, Sang Joon</au><au>Park, Myoung Hee</au><au>Ahn, Curie</au><au>Kim, Yon Su</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kidney transplantation in sensitized recipients; a single center experience</atitle><jtitle>Journal of Korean medical science</jtitle><addtitle>J Korean Med Sci</addtitle><date>2009-01</date><risdate>2009</risdate><volume>24 Suppl</volume><issue>Suppl 1</issue><spage>S143</spage><epage>S147</epage><pages>S143-S147</pages><issn>1011-8934</issn><eissn>1598-6357</eissn><abstract>A successful transplantation, across a positive crossmatch barrier, is one of the most persistent long-standing problems in the field of kidney transplant medicine. The aim of this study was to describe seven consecutive living renal transplantations in recipients with positive crossmatch for donors or positive for donor specific antibodies (DSAs). A preconditioning regimen including plasmapheresis and intravenous immunoglobulin was delivered three times a week until the crossmatch and/or DSAs became negative. Mycophenolate mofetil and tacrolimus were started two days before the plasmapheresis. The protocol was modified to include administration of anti-CD 20 antibody (rituximab, 375 mg/m(2)) from the patient number 3 through the patient number 7. All seven patients achieved negative conversion of the crossmatch or DSAs, and the kidney transplantations were successfully performed in all cases. Acute cellular rejection occurred in two patients, which were subclinical and controlled with high dose steroid treatment. Antibody-mediated rejection occurred in one patient, which was easily reversed with plasmapheresis. All recipients attained normal graft function during the 7-24 months of follow up. Our study suggests that sensitized patients can be transplanted successfully with desensitization pretreatment.</abstract><cop>Korea (South)</cop><pub>The Korean Academy of Medical Sciences</pub><pmid>19194544</pmid><doi>10.3346/jkms.2009.24.S1.S143</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1011-8934
ispartof Journal of Korean Medical Science, 2009, 24(0), , pp.143-147
issn 1011-8934
1598-6357
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_574478
source PubMed Central (Open Access)
subjects Adult
Antibodies, Monoclonal - pharmacology
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20 - biosynthesis
Biopsy
Female
Graft Rejection
Graft Survival
Histocompatibility Testing - methods
Humans
Immunoglobulins - chemistry
Kidney Transplantation - methods
Male
Middle Aged
Original
Plasmapheresis
Rituximab
Transplantation Conditioning
의학일반
title Kidney transplantation in sensitized recipients; a single center experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A25%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kidney%20transplantation%20in%20sensitized%20recipients;%20a%20single%20center%20experience&rft.jtitle=Journal%20of%20Korean%20medical%20science&rft.au=Kim,%20Sun%20Moon&rft.date=2009-01&rft.volume=24%20Suppl&rft.issue=Suppl%201&rft.spage=S143&rft.epage=S147&rft.pages=S143-S147&rft.issn=1011-8934&rft.eissn=1598-6357&rft_id=info:doi/10.3346/jkms.2009.24.S1.S143&rft_dat=%3Cproquest_nrf_k%3E66890969%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-aa9885754b7243e44da8a5dd02a5e80c9fc0386632ad06801440f6aeeb59d8173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66890969&rft_id=info:pmid/19194544&rfr_iscdi=true